$DMAC
DiaMedica Therapeutics Inc.

2023 Q1 Form 10-K Financial Statement

#000143774923008189 Filed on March 28, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.903M $1.703M $6.162M
YoY Change 21.83% 23.85% 26.24%
% of Gross Profit
Research & Development $3.618M $2.270M $7.839M
YoY Change 83.28% 21.33% -10.56%
% of Gross Profit
Depreciation & Amortization $7.000K $6.000K $25.00K
YoY Change 16.67% 0.0% 4.17%
% of Gross Profit
Operating Expenses $3.618M $3.973M $14.00M
YoY Change 83.28% 22.4% 2.6%
Operating Profit -$5.521M -$14.00M
YoY Change 56.14% 2.6%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $256.0K $229.0K $353.0K
YoY Change 631.43% 3171.43% 330.49%
Pretax Income -$5.265M -$3.744M -$13.65M
YoY Change 50.39% 15.59% 0.62%
Income Tax $7.000K $7.000K $28.00K
% Of Pretax Income
Net Earnings -$5.272M -$3.751M -$13.68M
YoY Change 50.29% 15.56% 0.62%
Net Earnings / Revenue
Basic Earnings Per Share -$0.20 -$0.52
Diluted Earnings Per Share -$0.20 -$0.14 -$0.52
COMMON SHARES
Basic Shares Outstanding 26.46M 26.44M 26.44M
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $28.66M $33.50M $33.50M
YoY Change -30.16% -32.74% -25.74%
Cash & Equivalents $2.147M $4.728M
Short-Term Investments $26.51M $28.77M $28.77M
Other Short-Term Assets $962.0K $251.0K $251.0K
YoY Change 7.37% 27.41% 27.41%
Inventory
Prepaid Expenses $870.0K $209.0K
Receivables $57.00K $82.00K $80.00K
Other Receivables $2.000K $2.000K $2.000K
Total Short-Term Assets $29.67M $33.84M $33.84M
YoY Change -29.53% -25.54% -25.54%
LONG-TERM ASSETS
Property, Plant & Equipment $136.0K $136.0K $560.0K
YoY Change 83.78% 94.29% 400.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $543.0K $560.0K $560.0K
YoY Change 443.0% 400.0% 400.0%
TOTAL ASSETS
Total Short-Term Assets $29.67M $33.84M $33.84M
Total Long-Term Assets $543.0K $560.0K $560.0K
Total Assets $30.22M $34.40M $34.40M
YoY Change -28.41% -24.49% -24.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.780M $734.0K $734.0K
YoY Change 311.09% 44.2% 44.2%
Accrued Expenses $956.0K $1.365M $1.428M
YoY Change -1.14% 41.3% 41.25%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $5.000K $6.000K $6.000K
YoY Change -16.67% 50.0% 50.0%
Total Short-Term Liabilities $2.814M $2.168M $2.168M
YoY Change 96.23% 42.26% 42.26%
LONG-TERM LIABILITIES
Long-Term Debt $4.000K $4.000K $4.000K
YoY Change -55.56% 33.33% 33.33%
Other Long-Term Liabilities $377.0K $396.0K $396.0K
YoY Change
Total Long-Term Liabilities $381.0K $400.0K $400.0K
YoY Change 4133.33% 13233.33% 13233.33%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.814M $2.168M $2.168M
Total Long-Term Liabilities $381.0K $400.0K $400.0K
Total Liabilities $3.195M $2.568M $2.568M
YoY Change 121.41% 68.17% 68.17%
SHAREHOLDERS EQUITY
Retained Earnings -$101.4M -$96.20M
YoY Change 17.91% 16.6%
Common Stock $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $27.00M $31.80M $31.83M
YoY Change
Total Liabilities & Shareholders Equity $30.22M $34.40M $34.40M
YoY Change -28.41% -24.49% -24.49%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$5.272M -$3.751M -$13.68M
YoY Change 50.29% 15.56% 0.62%
Depreciation, Depletion And Amortization $7.000K $6.000K $25.00K
YoY Change 16.67% 0.0% 4.17%
Cash From Operating Activities -$5.100M -$2.766M -$11.50M
YoY Change 30.77% -1.36% -6.5%
INVESTING ACTIVITIES
Capital Expenditures $7.000K $32.00K $81.00K
YoY Change -557.14% 268.18%
Acquisitions
YoY Change
Other Investing Activities $2.516M $4.756M $11.62M
YoY Change 13.64% -154.78% -156.64%
Cash From Investing Activities $2.509M $4.724M $11.54M
YoY Change 13.32% -154.37% -156.18%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$1.000K -1.000K -$6.000K
YoY Change 0.0% -94.74% -100.02%
NET CHANGE
Cash From Operating Activities -$5.100M -2.766M -$11.50M
Cash From Investing Activities $2.509M 4.724M $11.54M
Cash From Financing Activities -$1.000K -1.000K -$6.000K
Net Change In Cash -$2.581M 1.957M $21.00K
YoY Change 54.09% -117.0% -100.78%
FREE CASH FLOW
Cash From Operating Activities -$5.100M -$2.766M -$11.50M
Capital Expenditures $7.000K $32.00K $81.00K
Free Cash Flow -$5.107M -$2.798M -$11.58M
YoY Change 30.95% 0.04% -6.01%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
734000 usd
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001401040
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
0 usd
CY2022 us-gaap Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
Unlimited
CY2022Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
true
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Auditor Firm
AuditorFirmId
23
CY2022 dei Auditor Name
AuditorName
Baker Tilly US, LLP
CY2022 dei Auditor Location
AuditorLocation
Minneapolis, MN
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4728000 usd
CY2022Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
28774000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
251000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
82000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
33835000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
424000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
136000 usd
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
560000 usd
CY2022Q4 us-gaap Assets
Assets
34395000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1365000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6000 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4000 usd
CY2021Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
45000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2168000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3000 usd
CY2021Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
0 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
400000 usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
26443067
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
128078000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-74000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-96177000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
31827000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
34395000 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7839000 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6162000 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
14001000 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-14001000 usd
CY2022 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-23000 usd
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13699000 usd
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.52
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26443067
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
26014000 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
151000 usd
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
29849000 usd
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
244000 usd
CY2021 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
1558000 usd
CY2021 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-49000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-13592000 usd
CY2021Q4 us-gaap Shares Outstanding
SharesOutstanding
26443067
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
44024000 usd
CY2022 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
45684000 usd
CY2022 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
57303000 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
81000 usd
CY2022 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
CY2021 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
2000 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-20537000 usd
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
29849000 usd
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
244000 usd
CY2022 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
6000 usd
CY2021 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
6000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-6000 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
30087000 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
21000 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2702000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7409000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4728000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4707000 usd
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
27000 usd
CY2021 us-gaap Income Taxes Paid
IncomeTaxesPaid
28000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-96200000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-13700000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11500000 usd
CY2022Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
33500000 usd
CY2022Q4 dmac Working Capital
WorkingCapital
31700000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
31800000 usd
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<b><i>Concentration of credit risk</i></b>Financial instruments that potentially expose the Company to concentration of credit risk consist primarily of cash, cash equivalents and marketable securities. The Company maintains its cash balances primarily with two financial institutions. These balances generally exceed federally insured limits. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk in cash and cash equivalents. The Company believes that the credit risk related to marketable securities is limited due to the adherence to an investment policy focused on the preservation of principal.
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-13676000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-13592000 usd
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26443067
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20773399
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.52
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.65
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3181650
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2229259
CY2022Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
80000 usd
CY2021Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
130000 usd
CY2022Q4 us-gaap Other Receivables
OtherReceivables
2000 usd
CY2021Q4 us-gaap Other Receivables
OtherReceivables
0 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
82000 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
130000 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
209000 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
84000 usd
CY2022Q4 us-gaap Supplies
Supplies
42000 usd
CY2021Q4 us-gaap Supplies
Supplies
113000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
251000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
197000 usd
CY2021 us-gaap Variable Lease Cost
VariableLeaseCost
56000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
216000 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
137000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
80000 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
67000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
136000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
70000 usd
CY2022 us-gaap Depreciation
Depreciation
25000 usd
CY2021 us-gaap Depreciation
Depreciation
24000 usd
CY2022 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
12000 usd
CY2021 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
17000 usd
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
667000 usd
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
484000 usd
CY2022Q3 dmac Accrued Research And Professional Fees Current
AccruedResearchAndProfessionalFeesCurrent
215000 usd
CY2021Q4 dmac Accrued Research And Professional Fees Current
AccruedResearchAndProfessionalFeesCurrent
191000 usd
CY2022Q3 dmac Accrued Taxes And Other Liabilities Current
AccruedTaxesAndOtherLiabilitiesCurrent
11000 usd
CY2021Q4 dmac Accrued Taxes And Other Liabilities Current
AccruedTaxesAndOtherLiabilitiesCurrent
7000 usd
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1365000 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
966000 usd
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
78000 usd
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
65000 usd
CY2022 us-gaap Variable Lease Cost
VariableLeaseCost
25000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
97000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
109000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
113000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
116000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
119000 usd
CY2022Q3 dmac Lessee Operating Lease Liability Payments Due Year Six
LesseeOperatingLeaseLiabilityPaymentsDueYearSix
10000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
564000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
105000 usd
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
459000 usd
CY2021Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
7653060
CY2021Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
3.92
CY2021Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
30000000.0 usd
CY2021Q3 dmac Proceeds From Issuance Of Common Stock Net
ProceedsFromIssuanceOfCommonStockNet
29800000 usd
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
40000
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
244000 usd
CY2021 dmac Stock Issued During Period Shares Exercise Of Common Stock Warrants
StockIssuedDuringPeriodSharesExerciseOfCommonStockWarrants
0
CY2021 dmac Stock Issued During Period Shares Settlement Of Deferred Stock Units
StockIssuedDuringPeriodSharesSettlementOfDeferredStockUnits
3850
CY2022Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
5721910
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1502000 usd
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1558000 usd
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
611724
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
3.21
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1014398
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.04
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
316548
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
3.01
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
68437
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
3.14
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
1241137
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
2.31
CY2022Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
2782248
CY2022 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P7Y4M24D
CY2022Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
4.12
CY2022Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
1541111
CY2022 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
P6Y1M6D
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
244000 usd
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
2400000 usd
CY2022 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y8M12D
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0 usd
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
132000 usd
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2022 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.04 pure
CY2022 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
112000 usd
CY2021 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
87000 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
21000000 usd
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
17596000 usd
CY2022Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
817000 usd
CY2021Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
817000 usd
CY2022Q4 dmac Deferred Tax Assets Property Share Issue Costs
DeferredTaxAssetsPropertyShareIssueCosts
338000 usd
CY2021Q4 dmac Deferred Tax Assets Property Share Issue Costs
DeferredTaxAssetsPropertyShareIssueCosts
608000 usd
CY2022Q4 dmac Deferred Tax Assets Property Patents And Other
DeferredTaxAssetsPropertyPatentsAndOther
320000 usd
CY2021Q4 dmac Deferred Tax Assets Property Patents And Other
DeferredTaxAssetsPropertyPatentsAndOther
309000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
213000 usd
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
76000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
166000 usd
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
0 usd
CY2022Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
117000 usd
CY2021Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
13000 usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
22737000 usd
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
19393000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
22737000 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
19393000 usd
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.270 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.270 pure
CY2022 dmac Effective Income Tax Rate Reconciliation Income Tax Recovery Amount
EffectiveIncomeTaxRateReconciliationIncomeTaxRecoveryAmount
-3685000 usd
CY2021 dmac Effective Income Tax Rate Reconciliation Income Tax Recovery Amount
EffectiveIncomeTaxRateReconciliationIncomeTaxRecoveryAmount
-3656000 usd
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
340000 usd
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
421000 usd
CY2022 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
-33000 usd
CY2021 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
134000 usd
CY2022 dmac Income Tax Rate Reconciliation Share Issuance Costs Amount
IncomeTaxRateReconciliationShareIssuanceCostsAmount
0 usd
CY2021 dmac Income Tax Rate Reconciliation Share Issuance Costs Amount
IncomeTaxRateReconciliationShareIssuanceCostsAmount
-41000 usd
CY2022 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
62000 usd
CY2021 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
44000 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
3344000 usd
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
3126000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
28000 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
28000 usd

Files In Submission

Name View Source Status
dmac-20221231_cal.xml Edgar Link unprocessable
dmac-20221231_lab.xml Edgar Link unprocessable
0001437749-23-008189-index-headers.html Edgar Link pending
0001437749-23-008189-index.html Edgar Link pending
0001437749-23-008189.txt Edgar Link pending
0001437749-23-008189-xbrl.zip Edgar Link pending
dmac-20221231.xsd Edgar Link pending
dmtp20221231_10k.htm Edgar Link pending
ex_487860.htm Edgar Link pending
ex_487861.htm Edgar Link pending
ex_487862.htm Edgar Link pending
ex_487863.htm Edgar Link pending
ex_487864.htm Edgar Link pending
ex_487964.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pic1.jpg Edgar Link pending
pic2.jpg Edgar Link pending
pic3.jpg Edgar Link pending
pic4.jpg Edgar Link pending
pic5.jpg Edgar Link pending
pic6.jpg Edgar Link pending
pic7.jpg Edgar Link pending
pic8.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
dmac-20221231_def.xml Edgar Link unprocessable
dmac-20221231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
dmtp20221231_10k_htm.xml Edgar Link completed
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending